News Header Image

Issue of Equity and Loan Conversion



("Milestone" or the "Company")

Issue of Equity and Loan Conversion


Milestone (AIM:MSG), the AIM and Social Stock Exchange quoted provider of digital media and technology, announces that further to the announcement on 10 July 2017, the Company has received the final £1,100,000 of the agreed £1,500,000. It has therefore agreed to convert the £400,000 loan received to date and issue 522,626,906 new ordinary shares of 0.1 pence per share in the Company at a price of 0.29 pence per share for the £1,500,000 cash received, subject to admission to AIM.

Furthermore, the Company announces that it has agreed to issue 6,500,000 new ordinary shares of 0.1 pence per share in the Company, subject to admission to AIM, at a previously agreed price of 0.2 pence per share in lieu of a creditor balance of £13,000. This was agreed with the creditor when the share price was less than 0.2 pence per share and the board is keen to honour its commitment on price to this creditor.

The total of 529,126,906 new ordinary shares will rank pari passu with the existing ordinary shares of Milestone.

Application will be made for the 529,126,906 ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 21 September 2017.

Following the Issue of Equity, Milestone will have in issue 1,778,768,317 ordinary shares with voting rights.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information:

Milestone Group PLC
Tony Sanders

Tel: 020 7929 7826

Cairn Financial Advisers LLP, Nominated Adviser
Liam Murray/Sandy Jamieson

Tel: 020 7213 0880

Hybridan LLP, Broker
Claire Louise Noyce

Tel: 020 3764 2341

Walbrook PR Limited, PR
Gary Middleton / Paul Cornelius

Tel: 020 7933 8780